Role of ferritin alterations in human breast cancer cells (Q43100521)

13 November 2017

Role of ferritin alterations in human breast cancer cells (English)

1 reference

13 November 2017

6

1 reference

Athena Starlard-Davenport

13 November 2017

object named as

Athena Starlard-Davenport

4

0 references

Volodymyr Tryndyak

object named as

Volodymyr P Tryndyak

2

0 references

Igor P Pogribny

7

object named as

Igor P Pogribny

1 reference

13 November 2017

1

Svitlana I Shpyleva

1 reference

13 November 2017

Olga Kovalchuk

3

1 reference

13 November 2017

Vasy' F Chekhun

5

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Breast Cancer Research and Treatment

13 November 2017

1 reference

13 November 2017

126

1 reference

13 November 2017

1

1 reference

13 November 2017

63-71

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-010-0849-4

13 November 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Molecular mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Biomarkers and multiple drug resistance in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Resistance to chemotherapy: new treatments and novel insights into an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Role of iron in estrogen-induced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Does iron have a role in breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Ferritins: a family of molecules for iron storage, antioxidation and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Regulation of ferritin genes and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF-10F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Change in iron transporter expression in human term placenta with different maternal iron status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Analyzing real-time PCR data by the comparative C(T) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

The labile iron pool: characterization, measurement, and participation in cellular processes(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

The iron metabolism of neoplastic cells: alterations that facilitate proliferation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Role of iron in carcinogenesis: cancer as a ferrotoxic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Tissue ferritin concentration and prognosis in carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Rat ferritin-H: cDNA cloning, differential expression and localization during hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Identification of genes down-regulated during melanoma progression: a cDNA array study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

Gene targets of antisense therapies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0849-4

10.1007/S10549-010-0849-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 November 2017

0 references

1 reference